Novacyt expects FY 2024 revenue to nearly double to £19.6m, driven by the Yourgene acquisition and strong Reproductive Health growth. Operational consolidation and new product launches position the group for long-term expansion.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.